Navigation Links
Array BioPharma to Present at the NewsMakers in the Biotech Industry Conference
Date:9/24/2013

BOULDER, Colo., Sept. 24, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the NewsMakers in the Biotech Industry Conference.  The public is welcome to participate in the conference through webcasts on the Array BioPharma website:  www.arraybiopharma.com.(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)Event:NewsMakers in the Biotech Industry ConferenceDate:Friday, September 27, 2013Time:10:30 a.m. Eastern Time Location:Millennium Broadway Hotel, New York, NYAbout Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company and currently expects significant progress toward generating data to support our upcoming Phase 3 / pivotal trial decisions.
Novartis began a Phase 3 trial evaluating Array-invented MEK162 in patients with NRAS-mutant melanoma in July 2013 and expects to begin a Phase 3 trial in patients with BRAF-mutant melanoma in 2013.  In addition, Array began a Phase 3 trial evaluating MEK162 in patients with low-grade serous ovarian cancer under the license agreement with Novartis in June 2013.  AstraZeneca began a pivotal trial with Array-invented selumetinib in patients with thyroid cancer in May 2013 and expects to begin a Phase 3 trial in patients with non-small cell lung cancer in 2013.  Two other wholly-owned drugs, ARRY-520 and ARRY-614, are also approaching Phase 3 or pivotal trial decisions which are expected by the end of 2013.  For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Tricia Haugeto
Array BioPharma Inc.
303-386-1193
thaugeto@arraybiopharma.com


'/>"/>
SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. New palm-sized microarray technique grows 1,200 individual cultures of microbes
2. DNA Microarray 2013 Market Report: A Focus on Sales Growth
3. Markets for PCR, DNA Microarray, DNA Sequencing, Mass Spectrometry and Flow Cytometry to Exceed $50 billion by 2015
4. IBNs Droplet Array sheds light on drug-resistant cancer stem cells
5. Alios BioPharma initiates Phase 1 clinical trial for respiratory syncytial virus infection
6. Exclusive agreement to distribute Affinity Biosensors Archimedes system extends Malvern Instruments biopharma solutions
7. New research on potential avocado health benefits presented at International Congress of Nutrition
8. Cytos Biotechnology Presents Additional Results From Phase 2a Study of CYT003 for the Treatment of Allergic Asthma
9. Yin-yang effect of sodium and chloride presents salt conundrum
10. Amgen Presents Pooled Analysis Showing AMG 145 Significantly Reduced LDL Cholesterol In Over 1,200 Patients
11. Efficacy of acupressure to relieve migraine nausea presented at International Headache Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2019)... (PRWEB) , ... June 14, 2019 , ... ... Americans invited to lecture at the fifth annual Neodent World Congress. Attended by ... the innovative progress and latest advancements in the world of dentistry. The three-day ...
(Date:6/14/2019)... ... 14, 2019 , ... Molecular diagnostics segment is the fastest-growing segment within the ... Major segments that are expected to drive the growth are infectious diseases, cancer, ... segments in Kalorama’s The World Molecular Diagnostics Market, 8th Edition . , The ...
(Date:6/13/2019)... ... June 13, 2019 , ... Global Clinical ... serving the end-to-end clinical and ancillary supply chain management needs of large- and ... research organizations, today announced it will sponsor a summer education program offered by ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... ... 2019 , ... A study released today in STEM CELLS ... sustained release of human placental stem cell (HPSC)-derived conditioned medium (CM) to treat ... into the injured kidney, where it helped restore function and regenerate injured tissue. ...
(Date:5/14/2019)... HARBOR TOWNSHIP, N.J. (PRWEB) , ... May 13, ... ... manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical ... completely new Heliumleak.com company website. The redesigned website aims to improve LDA’s ability ...
(Date:5/4/2019)... BROOK, N.J. (PRWEB) , ... May 03, 2019 ... ... electrophysiology, announces the release of the Diopsys® ffERG/Photopic Negative Response vision ... of glaucoma. , By 2050, it is estimated that 6.3 million Americans will ...
(Date:5/2/2019)... ... May 02, 2019 , ... Boston Robotic Hair Restoration ... Gone are the days of painful hair transplant procedures. Boston Robotic Hair Restoration ... the only robotic intelligent solution to offer a minimally invasive procedure. With the ...
Breaking Biology Technology: